FINDINGS:
Researchers have found that a particular gene is central to the brain cancer glioblastoma and will either fight the tumor or, conversely, help the tumor advance, depending on the tumor’s genetic makeup.
RELEVANCE:
These findings are relevant for the emerging field of personalized medicine. Glioblastoma is a highly aggressive type of cancer for which treatments remain extremely limited. Researchers have long assumed that the gene in question, STAT3, only acts as a tumor inducer, and so have been developing therapeutics that inhibit STAT3. But if STAT3 actually fights tumors in a subset of these cancers, such therapies would do more harm than good. These results may change the way researchers approach not only glioblastoma but other types of cancers as well.
PRINCIPAL INVESTIGATOR:
Azad Bonni, Associate Professor of Pathology, Harvard Medical School
http://www.hmcnet.harvard.edu/pathol/labs/bonni/index.html
0 comments:
Post a Comment